NDC Package 69067-050-30 Glycopyrrolate

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

69067-050-30

Package Description:

30 TABLET in 1 BOTTLE

Product Code:

69067-050

Proprietary Name:

Glycopyrrolate

Usage Information:

Glycopyrrolate is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrrolate works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrrolate belongs to a class of drugs known as anticholinergics.

11-Digit NDC Billing Format:

69067005030

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

30 EA

Labeler Name:

Foxland Pharmaceuticals, Inc.

Sample Package:

FDA Application Number:

ANDA091522

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

10-10-2018

End Marketing Date:

05-31-2021

Listing Expiration Date:

05-31-2021

Exclude Flag:

Code Structure:

69067 - Foxland Pharmaceuticals, Inc.
- 69067-050 - Glycopyrrolate
  - 69067-050-30 - 30 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 69067-050-30?

The NDC Packaged Code 69067-050-30 is assigned to a package of 30 tablet in 1 bottle of Glycopyrrolate, labeled by Foxland Pharmaceuticals, Inc.. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

Is NDC 69067-050 included in the NDC Directory?

No, Glycopyrrolate with product code 69067-050 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Foxland Pharmaceuticals, Inc. on October 10, 2018 and its listing in the NDC Directory is set to expire on May 31, 2021 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 69067-050-30?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 69067-050-30?

The 11-digit format is 69067005030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	69067-050-30	5-4-2	69067-0050-30

Table of Contents